Jazz Pharmaceuticals JAZZ Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's operating income?
- Jazz Pharmaceuticals (JAZZ) reported operating income of $336.6M in Q1 2026.
- How has Jazz Pharmaceuticals's operating income changed year-over-year?
- Jazz Pharmaceuticals's operating income increased by 702.1% year-over-year, from -$55.9M to $336.6M.
- What is the long-term trend for Jazz Pharmaceuticals's operating income?
- Over 3 years (2021 to 2024), Jazz Pharmaceuticals's operating income has grown at a 61.5% compound annual growth rate (CAGR), from $170.28M to $716.63M.
- What does operating income mean?
- Profit earned from core business operations before interest and taxes.
- How do you interpret operating income?
- Positive and growing operating income is a key indicator of a sustainable and scalable business model.
- How does operating income compare across companies?
- Standard measure of operational efficiency across all industries.